These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23810374)

  • 1. Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013.
    Girard MP; Tam JS; Pervikov Y; Katz JM
    Vaccine; 2013 Aug; 31(37):3766-71. PubMed ID: 23810374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.
    Cox NJ; Hickling J; Jones R; Rimmelzwaan GF; Lambert LC; Boslego J; Rudenko L; Yeolekar L; Robertson JS; Hombach J; Ortiz JR
    Vaccine; 2015 Nov; 33(48):6503-10. PubMed ID: 26478203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
    Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
    Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009.
    Hayden FG; Howard WA; Palkonyay L; Kieny MP
    Vaccine; 2009 Jun; 27(31):4079-89. PubMed ID: 19406184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.
    Ortiz JR; Hickling J; Jones R; Donabedian A; Engelhardt OG; Katz JM; Madhi SA; Neuzil KM; Rimmelzwaan GF; Southern J; Spiro DJ; Hombach J
    Vaccine; 2018 Feb; 36(7):932-938. PubMed ID: 29221895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009.
    Stephenson I; Hayden F; Osterhaus A; Howard W; Pervikov Y; Palkonyay L; Kieny MP
    Vaccine; 2010 May; 28(23):3875-82. PubMed ID: 20398616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.
    Hampson A; Barr I; Cox N; Donis RO; Siddhivinayak H; Jernigan D; Katz J; McCauley J; Motta F; Odagiri T; Tam JS; Waddell A; Webby R; Ziegler T; Zhang W
    Vaccine; 2017 Feb; 35(8):1104-1109. PubMed ID: 28131392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
    Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16-17 November 2011.
    Hughes B; Hayden F; Perikov Y; Hombach J; Tam JS
    Vaccine; 2012 Oct; 30(47):6612-22. PubMed ID: 22981850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines for seasonal and pandemic influenza.
    Nichol KL; Treanor JJ
    J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010.
    Girard MP; Katz J; Pervikov Y; Palkonyay L; Kieny MP
    Vaccine; 2010 Oct; 28(42):6811-20. PubMed ID: 20659520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
    Poland GA; Fleming DM; Treanor JJ; Maraskovsky E; Luke TC; Ball EM; Poland CM
    Vaccine; 2013 Apr; 31 Suppl 1():A1-20. PubMed ID: 23587330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    Rudraraju R; Mordant F; Subbarao K
    J Infect Dis; 2019 Apr; 219(Suppl_1):S81-S87. PubMed ID: 30715386
    [No Abstract]   [Full Text] [Related]  

  • 14. Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
    Innis BL; Berlanda Scorza F; Blum JS; Jain VK; Older Aguilar A; Post DJ; Roberts PC; Wairagkar N; White J; Bresee J
    Vaccine; 2019 Aug; 37(35):4823-4829. PubMed ID: 31362819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
    Rudenko L; Yeolekar L; Kiseleva I; Isakova-Sivak I
    Vaccine; 2016 Oct; 34(45):5436-5441. PubMed ID: 27593158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.
    Rosendahl Huber SK; Hendriks M; Jacobi RHJ; van de Kassteele J; Mandersloot-Oskam JC; van Boxtel RAJ; Wensing AMJ; Rots NY; Luytjes W; van Beek J
    Front Immunol; 2018; 9():3103. PubMed ID: 30761157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005.
    Hampson AW; Osterhaus AD; Pervikov Y; Kieny MP
    Vaccine; 2006 Jun; 24(23):4897-4900. PubMed ID: 16823947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.
    Cowling BJ; Ng S; Ma ES; Cheng CK; Wai W; Fang VJ; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM
    Clin Infect Dis; 2010 Dec; 51(12):1370-9. PubMed ID: 21067351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from the H1N1 2009 pandemic.
    Petrovsky N
    Hum Vaccin; 2010 Oct; 6(10):780-3. PubMed ID: 20935468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Live attenuated and inactivated influenza vaccines: data from direct comparative studies].
    Kashirina OS; Vasil'ev IuM
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):103-19. PubMed ID: 24738303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.